Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4905354 | 1.00 | LMNA (0.46) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL21895839 | 0.94 | LMNA (0.46) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL4227180 | 0.93 | LMNA (0.59) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL316330 | 0.93 | LMNA (0.59) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL11683348 | 0.85 | LMNA (0.56) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL1285198 | 0.82 | — | — | |
| SCHEMBL6795092 | 0.81 | — | — | |
| SCHEMBL11389165 | 0.79 | ALDH1A1 (0.32) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL2557058 | 0.79 | LMNA (0.42) | LMNAMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL14247972 | 0.79 | ALDH1A1 (0.32) | MEN1CYP3A4ALOX15KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3621577-B1 | NOVEL FRAGRANCE COMPOSITIONS AND PRODUCTS WITH MOOD ENHANCING EFFECTS | SYMRISE AG (DE) | 2021-06-30 | — | — | EP | claimed |
| WO-2019193024-A1 | IMPROVEMENTS IN OR RELATING TO A PERFUME COMPOSITION FOR USE IN AN AIR FRESHENER DEVICE | GIVAUDAN SA (CH) | 2019-10-10 | — | — | WO | claimed |
| US-9816043-B1 | Acyclic monoterpenes as biofuels based on linalool and method for making the same | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2017-11-14 | — | — | US | claimed |
| EP-3197507-A1 | MALODOR REDUCTION COMPOSITIONS | The Procter and Gamble Company (US) | 2017-08-02 | — | — | EP | claimed |
| WO-2016049389-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-9266798-B1 | Acyclic monoterpenes as biofuels based on linalool and method for making the same | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2016-02-23 | — | — | US | claimed |
| US-9205232-B2 | Balloon for catheter and balloon catheter | TERUMO KABUSHIKI KAISHA (JP) | 2015-12-08 | — | — | US | claimed |
| US-8987539-B1 | Acyclic monoterpenes as biofuels based on linalool and method for making the same | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2015-03-24 | — | — | US | claimed |
| US-20130085519-A1 | BALLOON FOR CATHETER AND BALLOON CATHETER | TERUMO KABUSHIKI KAISHA (JP) | 2013-04-04 | — | — | US | claimed |
| EP-2512428-A1 | COSMETIC COMPOSITION COMPRISING A SUPRAMOLECULAR COMPOUND CAPABLE OF ESTABLISHING HYDROGEN BONDS, AND A PARTICULAR OIL | L'Oréal (FR) | 2012-10-24 | — | — | EP | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| EP-1023260-B1 | PROCESS FOR PREPARING BETA-KETOESTER FRAGRANCE PRO-ACCORDS FROM 1,3-DIOXAN-4,6-DIONES | PROCTER & GAMBLE (US) | 2004-01-28 | — | — | EP | claimed |
| US-6500797-B1 | Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones | THE PROCTER & GAMBLE COMPANY | 2002-12-31 | — | — | US | claimed |
| EP-0909750-B1 | Process for the preparation of gamma, delta-unsaturated ketones ba Carroll-reaciton, catalysts for this process and their preparation | BASF AG (DE) | 2002-09-18 | — | — | EP | claimed |
| EP-1023260-A1 | PROCESS FOR PREPARING BETA-KETOESTER FRAGRANCE PRO-ACCORDS FROM 1,3-DIOXAN-4,6-DIONES | THE PROCTER & GAMBLE COMPANY (US) | 2000-08-02 | — | — | EP | claimed |
| WO-1999016740-A1 | PROCESS FOR PREPARING BETA-KETOESTER FRAGRANCE PRO-ACCORDS FROM 1,3-DIOXAN-4,6-DIONES | THE PROCTER & GAMBLE COMPANY (US) | 1999-04-08 | — | — | WO | claimed |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| EP-4677050-A1 | MARINE LUBRICANTS ENABLING FUTURE FUELS | Chevron Oronite Company LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| US-4048425-A | ACRYLIC ESTERS, MONO-OLEFINS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1977-09-13 | — | — | US | disclosed |
| US-3959225-A | Thermally-staged polymer process | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | LMNA 4529/4885MEN1 4220/4885CYP3A4 2348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.